Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cambien

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|February 4, 1995
Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistanceJ Emmerich, O Poirier, A Evans, et al.
Kidney International|April 29, 1998
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathyP Jacobsen, K Rossing, P Rossing, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 1997
Awareness and control of hypertension and hypercholesterolaemia in France and Northern IrelandP Marques-Vidal, A E Evans, J P Cambou, et al.
Atherosclerosis|June 1, 1997
Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotypeG Luc, P Ducimetiere, J M Bard, et al.
Atherosclerosis|June 1, 1995
Cardiovascular risk factors and alcohol consumption in France and Northern IrelandP Marques-Vidal, J P Cambou, V Nicaud, et al.
Thrombosis and Haemostasis|June 1, 1997
The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du MyocardeS M Herrmann, O Poirier, P Marques-Vidal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathyL Tarnow, C D Stehouwer, J J Emeis, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Atherosclerosis|August 1, 1995
Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du MyocardeT Brousseau, D Arveiler, J P Cambou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathyL Tarnow, F Cambien, P Rossing, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|February 4, 1995
Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistanceJ Emmerich, O Poirier, A Evans, et al.
Kidney International|April 29, 1998
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathyP Jacobsen, K Rossing, P Rossing, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 1997
Awareness and control of hypertension and hypercholesterolaemia in France and Northern IrelandP Marques-Vidal, A E Evans, J P Cambou, et al.
Atherosclerosis|June 1, 1997
Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotypeG Luc, P Ducimetiere, J M Bard, et al.
Atherosclerosis|June 1, 1995
Cardiovascular risk factors and alcohol consumption in France and Northern IrelandP Marques-Vidal, J P Cambou, V Nicaud, et al.
Thrombosis and Haemostasis|June 1, 1997
The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du MyocardeS M Herrmann, O Poirier, P Marques-Vidal, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathyL Tarnow, C D Stehouwer, J J Emeis, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Atherosclerosis|August 1, 1995
Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du MyocardeT Brousseau, D Arveiler, J P Cambou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathyL Tarnow, F Cambien, P Rossing, et al.
Pageof 18